Login
← Go Back
Alivus Life Sciences
ALIVUS · Pharma > Pharmaceuticals & Drugs · Chairman: Glenn Saldanha · MD: Yasir Rawjee · Listing date: Aug. 7, 2021 · Employees: 1537 · Mumbai · http://www.glenmarklifesciences.com
Stock Price vs Company Growth
1d
0.9%
1w
0.8%
1m
2.1%
3m
5.0%
6m
11.7%
1y
13.5%
all
7.3%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 890 0.9%
848
1,078
Company Overview
Sales
2,481 Cr
Growth: 5.6%
Profit after Tax
530 Cr
Growth: 7.0%
Mid Cap
10,918 Cr
P/E: 20.6x
Industry P/E: 33.1x
Fundamentals
Sales (Cr) ₹ 2,481
Growth 5.6%
EBITDA 29.8%
P/S 4.4x
Dividend 0.0%
P/E 20.6x
Book Value ₹ 250
PEG Ratio 3.6x
ROE 18.4%
P/B 3.5x
Shareholding Pattern
Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed
The company is in the business of making high-quality drugs by unlocking the possibilities of science.Awards, accreditations and recognitions2015: Ankleshwar plant received ISO 14001:2015 certifying the management system of manufacturing facility.2016: Dahej plant received ISO 14001:2015 certifying the management system of manufacturing facility.2016: Ankleshwar plant received BS OHSAS 18001:2017 certifying the management system of the manufacturing facility.
Belongs to (10 Indices) view more
Investors (7)
societe....
icici.pr...
nirma
Followers (2)
atharav
varsha96